Lab Manager | Run Your Lab Like a Business

Diagenode to Offer Single-Cell ATAC-Seq Services Featuring Bio-Rad’s Droplet Digital Technology

Diagenode’s scATAC-Seq Services leverage the combined capabilities of Bio-Rad’s Droplet Digital technology and Diagenode’s epigenetics expertise to help researchers gain a greater understanding of the epigenome

by Bio-Rad Laboratories
Register for free to listen to this article
Listen with Speechify
0:00
5:00

DENVILLE, NJ and HERCULES, CA — Diagenode, Inc., a leading global provider of solutions for epigenetics research and sample preparation, and Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today (Nov. 19) announced a partnership in which Diagenode will offer Single-Cell ATAC-Seq (scATAC-Seq) Services, featuring Bio-Rad’s Droplet Digital technology, to help advance epigenomics research.

Diagenode’s scATAC-Seq Services leverage the combined capabilities of Bio-Rad’s Droplet Digital technology and Diagenode’s epigenetics expertise to help researchers gain a greater understanding of the epigenome, the multitude of chemical compounds and proteins that give instructions to the genome. The scATAC-Seq Services utilize Bio-Rad’s ddSEQ Single-Cell Isolator to encapsulate thousands of cell nuclei or whole cells into nanoliter-sized droplets and offer robust precision and quantification of data.

scATAC-Seq solutions enable the genome-wide study of accessible chromatin that represents regulatory regions at the single-cell level. In contrast to standard bulk ATAC-Seq, scATAC-Seq provides a way for thousands of cells to be assessed in parallel to better parse heterogeneous populations.

“We are excited to offer scientists the combination of Diagenode’s epigenetic service excellence and Bio-Rad’s industry-leading scATAC-Seq technology,” said Joe Bertelsen, business unit manager at Diagenode. “This collaboration demonstrates our continued commitment to enabling advances in epigenomics research.”

“Bio-Rad is pleased to partner with Diagenode, a key player in the epigenetics market,” said Kris Simonyi, global marketing manager at Bio-Rad’s Digital Biology Group. “By working together to combine our expertise, we look forward to accelerating epigenetics and gene regulation research at the single-cell level.”

To learn more about Diagenode’s Single-Cell ATAC-Seq Services, please visit: https://www.diagenode.com/p/single-cell-atac-seq-service

BIO-RAD, DDPCR, and DROPLET DIGITAL PCR are trademarks of Bio-Rad Laboratories, Inc. in certain jurisdictions.